Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Therapy
| dc.contributor.author | Burke, Aidan M. | |
| dc.contributor.author | Carrasquilla, Michael | |
| dc.date.accessioned | 2022-11-30T15:36:19Z | |
| dc.date.available | 2022-11-30T15:36:19Z | |
| dc.date.issued | 2022-01-12 | |
| dc.identifier.doi | 10.3389/fonc.2021.794615 | |
| dc.identifier.issn | 2234-943X | |
| dc.identifier.uri | http://hdl.handle.net/10342/11791 | |
| dc.language.iso | en_US | en_US |
| dc.subject | brain metastases | en_US |
| dc.subject | immunotherapy | en_US |
| dc.subject | radiation necrosis | en_US |
| dc.title | Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Therapy | en_US |
| dc.type | Article | en_US |
| ecu.journal.name | Frontiers in Oncology | en_US |
| ecu.journal.volume | 11 | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- BurkeVolumeofDiseaseasaPredictorforClinicalOutcomesinPatientsWithMelanomaBrainMetastases.pdf
- Size:
- 722.78 KB
- Format:
- Adobe Portable Document Format
- Description: